Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,535 | 58,176 | 61,688 | 165,753 | 84,772 |
| Marketable Securities | 312,166 | 508,675 | 388,557 | 387,129 | 276,817 |
| Receivables | 27,116 | 21,179 | 16,646 | 15,914 | 33,067 |
| Inventories | 6,200 | 9,410 | 4,523 | 7,313 | 7,608 |
| Other current assets | 0 | 0 | 2,990 | 0 | 0 |
| TOTAL | $416,702 | $616,775 | $486,437 | $582,827 | $410,407 |
| Non-Current Assets | |||||
| PPE Net | 5,336 | 7,479 | 9,049 | 11,106 | 9,418 |
| Intangibles | 103,974 | 104,443 | 97,073 | 148,435 | 154,125 |
| Other Non-Current Assets | 68,113 | 60,216 | 80,026 | 34,265 | 33,489 |
| TOTAL | $177,423 | $172,138 | $186,148 | $193,806 | $197,032 |
| Total Assets | $594,125 | $788,913 | $672,585 | $776,633 | $607,439 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,534 | 41,675 | 17,290 | 15,144 | 12,133 |
| Accrued Expenses | 86,028 | 118,991 | 95,742 | 75,180 | 56,793 |
| Other current liabilities | 14,291 | 5,237 | 5,722 | 13,588 | 23,377 |
| TOTAL | $200,751 | $177,908 | $142,163 | $124,088 | $92,660 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,815 | 7,096 | 11,976 | 16,268 | N/A |
| Other Non-Current Liabilities | 334,297 | 410,195 | 476,640 | 330,054 | 303,566 |
| TOTAL | $334,297 | $410,195 | $487,571 | $350,433 | $303,566 |
| Total Liabilities | $535,048 | $588,103 | $629,734 | $474,521 | $396,226 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,740 | 76,098 | 64,745 | 63,212 | 60,236 |
| Common Shares | 9 | 7 | 6 | 6 | 5 |
| Retained earnings | -1,447,167 | -1,125,622 | -1,014,223 | -765,966 | -585,875 |
| Other shareholders' equity | -80 | -1,456 | -2,907 | -562 | -902 |
| TOTAL | $59,077 | $200,810 | $42,851 | $302,112 | $211,213 |
| Total Liabilities And Equity | $594,125 | $788,913 | $672,585 | $776,633 | $607,439 |